Aterian (NASDAQ:ATER – Get Rating) announced its quarterly earnings results on Monday. The company reported ($0.25) earnings per share (EPS) for the quarter, meeting the consensus estimate of ($0.25), Fidelity Earnings reports. Aterian had a negative return on equity of 42.93% and a negative net margin of 94.74%. During the same quarter in the prior year, the business posted ($0.64) earnings per share.
Shares of Aterian stock opened at $3.99 on Tuesday. Aterian has a 12-month low of $2.10 and a 12-month high of $21.07. The company has a market capitalization of $247.76 million, a price-to-earnings ratio of -0.52 and a beta of 1.25. The firm’s 50-day moving average price is $3.71 and its two-hundred day moving average price is $4.18.
A number of analysts have recently issued reports on the stock. DA Davidson cut their target price on shares of Aterian from $14.00 to $7.00 in a research note on Wednesday, March 9th. Alliance Global Partners reduced their price objective on Aterian from $9.00 to $4.50 in a report on Friday, March 11th. Zacks Investment Research lowered Aterian from a “buy” rating to a “hold” rating in a research note on Tuesday, May 3rd. Finally, BTIG Research dropped their price objective on shares of Aterian from $9.00 to $5.00 and set a “buy” rating for the company in a research note on Wednesday, March 9th. Two research analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Based on data from MarketBeat.com, Aterian has an average rating of “Buy” and a consensus target price of $13.83.
Large investors have recently added to or reduced their stakes in the stock. Cubist Systematic Strategies LLC lifted its holdings in shares of Aterian by 53.6% in the fourth quarter. Cubist Systematic Strategies LLC now owns 150,339 shares of the company’s stock worth $618,000 after acquiring an additional 52,485 shares during the last quarter. Squarepoint Ops LLC bought a new position in Aterian in the 4th quarter valued at approximately $572,000. Goldman Sachs Group Inc. lifted its holdings in shares of Aterian by 435.2% during the fourth quarter. Goldman Sachs Group Inc. now owns 83,596 shares of the company’s stock worth $344,000 after purchasing an additional 67,975 shares during the period. Charles Schwab Investment Management Inc. grew its stake in shares of Aterian by 22.8% in the fourth quarter. Charles Schwab Investment Management Inc. now owns 80,743 shares of the company’s stock worth $332,000 after purchasing an additional 15,012 shares during the last quarter. Finally, Schonfeld Strategic Advisors LLC acquired a new stake in shares of Aterian in the fourth quarter valued at about $302,000. 17.13% of the stock is currently owned by institutional investors and hedge funds.
Aterian Company Profile (Get Rating)
Aterian, Inc, together with its subsidiaries, operates as a technology-enabled consumer products company in North America and internationally. The company provides Artificial Intelligence Marketplace e-Commerce Engine, a software technology platform, which uses machine learning, natural language processing, and data analytics to design, develop, market, and sell products.
Featured Articles
- Get a free copy of the StockNews.com research report on Aterian (ATER)
- Shopify (NYSE: SHOP) Approaches Key Support Level
- Intuitive Surgical is an Intuitive Buy
- The Low In Lordstown Motors May Not Be The LastÂ
- Follow The Money To Cigna
- MarketBeat Podcast: Barbell Strategy To Strengthen Your Portfolio
Receive News & Ratings for Aterian Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aterian and related companies with MarketBeat.com's FREE daily email newsletter.